Balendra, R;
Al Khleifat, A;
Fang, T;
Al-Chalabi, A;
(2019)
A standard operating procedure for King's ALS clinical staging.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
, 20
(3-4)
pp. 159-164.
10.1080/21678421.2018.1556696.
Preview |
Text
Balendra_12_03_2019_A standard.pdf - Published Version Download (712kB) | Preview |
Abstract
OBJECTIVE: Clinical stages in amyotrophic lateral sclerosis (ALS) can be measured using a simple system based on the number of CNS regions involved and requirement for gastrostomy or noninvasive ventilation (NIV). We aimed to design a standard operating procedure (SOP) to define the standardized use and application of the King's staging system. // METHODS: We designed a SOP for the King's staging system. We wrote case vignettes representative of ALS patients at different disease stages. During two workshops, we taught health care professionals how to use the SOP, then asked them to stage the vignettes using the SOP. We measured the extent to which SOP staging corresponded with correct clinical stage. // RESULTS: The reliability of staging using the SOP was excellent, with a Spearman's Rank coefficient of 0.95 (p < 0.001), and was high for different groups of health care professionals, and for those with different levels of experience in ALS. The limits of agreement between SOP staging and actual clinical stage lie within a single stage, confirming that there is a clinically acceptable level of agreement between staging using the SOP and actual King's clinical stage. There were also no systematic biases of the SOP over the range of stages, either for over-staging or under-staging. // CONCLUSIONS: We have demonstrated that the staging SOP provides a reliable method of calculating clinical stages in ALS patients and can be used prospectively by a range of health care professionals with different levels of experience, as for example may be the case in multicentre clinical trials.
| Type: | Article |
|---|---|
| Title: | A standard operating procedure for King's ALS clinical staging |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1080/21678421.2018.1556696 |
| Publisher version: | https://doi.org/10.1080/21678421.2018.1556696 |
| Language: | English |
| Additional information: | © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| Keywords: | Clinical trials, prognostic, staging, standard operating procedure, survival |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10069905 |
Archive Staff Only
 |
View Item |
